Evidence map›Paper›PMID 40867576›Full record

ReviewBiomolecules2025

Therapeutic Applications and Mechanisms of Superoxide Dismutase (SOD) in Different Pathogenesis.

Shehwaz Anwar, Tarique Sarwar, Amjad Ali Khan, Arshad Husain Rahmani

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. CuBioactive materials · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Dietary Encapsulation of a NovelAntioxidants (Basel, Switzerland) · 2026
    Article
  12. Role of cuproptosis in digestive system tumors (Review).International journal of molecular medicine · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Frontiers in pharmacology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shehwaz AnwarDepartment of Medical Laboratory Technology, Mohan Institute of Nursing and Paramedical Sciences, Bareilly 243302, India.ORCID 0000-0003-3448-9353
Tarique SarwarDepartment of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.ORCID 0000-0003-2811-220X
Amjad Ali KhanDepartment of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.ORCID 0000-0001-6030-4493
Arshad Husain RahmaniDepartment of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An imbalance between the generation of reactive oxygen species (ROS) and antioxidant defenses is known as oxidative stress, and it is implicated in a number of diseases. The superoxide radical O

Indexed as

NeoplasmsSuperoxide DismutaseSuperoxide Dismutase-1AnimalsAntioxidantsHumansOxidative StressReactive Oxygen SpeciesAntioxidantsReactive Oxygen SpeciesSuperoxide DismutaseSuperoxide Dismutase-1antioxidant defensesoxidative stressreactive oxygen speciessuperoxide dismutasetherapeutic potential

Identifiers

PMID40867576
PMCPMC12384489

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.